AntidiabeticsSOLUTIONStandard
KIRSTY
INSULIN ASPART-XJHZ
Standard Dose
100 UNITS/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview KIRSTY is listed in Drugs@FDA under application 761188 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN ASPART-XJHZ Form and strength INJECTION;SOLUTION - 100 UNITS/ML Sponsor BIOCON BIOLOGICS INC Submission history Latest submission status date: 2025-07-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview KIRSTY is listed in Drugs@FDA under application 761188 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN ASPART-XJHZ Form and strength INJECTION;SOLUTION - 100 UNITS/ML Sponsor BIOCON BIOLOGICS INC Submission history Latest submission status date: 2025-07-15 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.